• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性甲状腺淋巴瘤的发病情况和预后因素,以及化疗和手术后患者的预后模型构建:一项基于人群的研究。

Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study.

机构信息

Department of Pathology, Wannan Medical College, Wenchang West Road 22, Wuhu, Anhui, China.

Department of Health Inspection and Quarantine, Wannan Medical College, Wenchang West Road 22, Wuhu, Anhui, China.

出版信息

BMC Endocr Disord. 2021 Apr 13;21(1):68. doi: 10.1186/s12902-021-00732-7.

DOI:10.1186/s12902-021-00732-7
PMID:33849490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8045392/
Abstract

BACKGROUND

Primary thyroid lymphoma (PTL) is a rare thyroid malignancy, there are few large sample studies on PTL and no standardized treatment regimen has been established due to the rarity. The aims of this study were to explore the incidence and prognostic factors of PTL and construct visual prognostic prediction models for post-chemotherapy and postoperative patients.

METHODS

The incidence of PTL in 1975-2017 was extracted from the US Surveillance, Epidemiology, and End Results (SEER) database, then assessed using joinpoint regression software. A total of 1616 eligible PTL patients diagnosed in 1998-2016 were brought into prognostic analysis. Multivariate Cox regression analyses were carried out to reveal independent prognostic elements for overall survival (OS) and cancer-specific survival (CSS).

RESULTS

PTL incidence showed a relatively steady increase in 1975-1994, which annual percent change (APC) was 4.0%, and steady decreasing in 1994-2017(APC - 2.4%). Age, marital status, lymphoma Ann Arbor stage, histological subtypes, surgery, chemotherapy, and radiation were significantly correlated to OS and CSS. Nomograms were constructed to predict OS and CSS in post-chemotherapy and postoperative PTL patients separately, and were verified to have good reliability.

CONCLUSIONS

The incidence of PTL increased and subsequently decreased. We revealed the prognostic implications and constructed reliable nomograms for post-chemotherapy and postoperative PTL patients.

摘要

背景

原发性甲状腺淋巴瘤(PTL)是一种罕见的甲状腺恶性肿瘤,由于其罕见性,对 PTL 的大型样本研究较少,尚未建立标准化的治疗方案。本研究旨在探讨 PTL 的发病率和预后因素,并为化疗后和手术后患者构建可视化预后预测模型。

方法

从美国监测、流行病学和最终结果(SEER)数据库中提取 1975-2017 年 PTL 的发病率,然后使用 joinpoint 回归软件进行评估。对 1998-2016 年诊断的 1616 例合格 PTL 患者进行预后分析。采用多变量 Cox 回归分析揭示总生存(OS)和癌症特异性生存(CSS)的独立预后因素。

结果

PTL 发病率在 1975-1994 年呈相对稳定增长,年变化百分比(APC)为 4.0%,1994-2017 年呈稳定下降(APC-2.4%)。年龄、婚姻状况、淋巴瘤 Ann Arbor 分期、组织学亚型、手术、化疗和放疗与 OS 和 CSS 显著相关。分别为化疗后和手术后 PTL 患者构建了预测 OS 和 CSS 的列线图,并验证了其具有良好的可靠性。

结论

PTL 的发病率增加,随后减少。我们揭示了预后意义,并为化疗后和手术后 PTL 患者构建了可靠的列线图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/bd3c9fb78376/12902_2021_732_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/0de1a6bc2f07/12902_2021_732_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/3db41a8a9a68/12902_2021_732_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/40494bbe31cd/12902_2021_732_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/a5e01c0b57a1/12902_2021_732_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/ccc0acfd96c4/12902_2021_732_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/d358dc3f159c/12902_2021_732_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/bd3c9fb78376/12902_2021_732_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/0de1a6bc2f07/12902_2021_732_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/3db41a8a9a68/12902_2021_732_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/40494bbe31cd/12902_2021_732_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/a5e01c0b57a1/12902_2021_732_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/ccc0acfd96c4/12902_2021_732_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/d358dc3f159c/12902_2021_732_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/bd3c9fb78376/12902_2021_732_Fig7_HTML.jpg

相似文献

1
Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study.原发性甲状腺淋巴瘤的发病情况和预后因素,以及化疗和手术后患者的预后模型构建:一项基于人群的研究。
BMC Endocr Disord. 2021 Apr 13;21(1):68. doi: 10.1186/s12902-021-00732-7.
2
Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort.基于 SEER 数据库和外部验证队列的原发性甲状腺淋巴瘤预后评估模型。
J Endocrinol Invest. 2022 Apr;45(4):815-824. doi: 10.1007/s40618-021-01712-3. Epub 2021 Dec 4.
3
Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival.原发性乳腺淋巴瘤患者的流行病学特征和生存预测列线图的建立。
Breast. 2021 Jun;57:49-61. doi: 10.1016/j.breast.2021.03.006. Epub 2021 Mar 17.
4
Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study.基于人群的研究:预测恶性外周神经鞘瘤患者总生存和特定原因生存的列线图。
J Neurooncol. 2019 Jul;143(3):495-503. doi: 10.1007/s11060-019-03181-4. Epub 2019 May 14.
5
Epidemiological features for primary lymphoma of the female genital tract patients and development of a nomogram to predict survival.女性生殖道原发性淋巴瘤患者的流行病学特征及生存预测列线图的建立。
Ann Med. 2022 Dec;54(1):962-976. doi: 10.1080/07853890.2022.2046289.
6
Prognostic Nomogram and Competing Risk Analysis of Death for Primary Thyroid Lymphoma: A Long-term Survival Study of 1638 Patients.原发性甲状腺淋巴瘤死亡的预后列线图及竞争风险分析:1638例患者的长期生存研究
Ann Surg Open. 2022 Nov 29;3(4):e226. doi: 10.1097/AS9.0000000000000226. eCollection 2022 Dec.
7
Incidence and survival trends in patients with primary tonsillar lymphoma: a large population-based study.原发扁桃体淋巴瘤患者的发病和生存趋势:一项大型基于人群的研究。
Eur Arch Otorhinolaryngol. 2022 Aug;279(8):4023-4032. doi: 10.1007/s00405-022-07363-1. Epub 2022 Apr 9.
8
The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.原发性心脏淋巴瘤患者的发病和生存结局:基于 SEER 的分析。
Hematol Oncol. 2020 Aug;38(3):334-343. doi: 10.1002/hon.2741. Epub 2020 Apr 29.
9
The epidemiology and prognosis of patients with primary gastric T-cell lymphoma in the SEER program.SEER 项目中原发性胃 T 细胞淋巴瘤患者的流行病学和预后。
Cancer Med. 2023 Jan;12(1):84-98. doi: 10.1002/cam4.4936. Epub 2022 Jun 13.
10
Nomograms Predict Survival Outcome of Primary Intramedullary Spinal Cord Lymphoma Patients.列线图预测原发性脊髓内淋巴瘤患者的生存结局。
Med Sci Monit. 2019 Oct 3;25:7418-7429. doi: 10.12659/MSM.919628.

引用本文的文献

1
Bibliometric analysis and visualization of global research trends in primary thyroid lymphoma via CiteSpace.通过CiteSpace对原发性甲状腺淋巴瘤全球研究趋势进行文献计量分析和可视化
Gland Surg. 2024 Nov 30;13(11):2078-2097. doi: 10.21037/gs-24-317. Epub 2024 Nov 26.
2
[Clinical characteristics and prognostic analysis of 34 patients with primary thyroid lymphoma].34例原发性甲状腺淋巴瘤患者的临床特征及预后分析
Zhonghua Xue Ye Xue Za Zhi. 2024 May 14;45(5):495-499. doi: 10.3760/cma.j.cn121090-20240220-00068.
3
The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.

本文引用的文献

1
Hashimoto's thyroiditis and primary thyroid lymphoma.桥本甲状腺炎与原发性甲状腺淋巴瘤。
QJM. 2020 Sep 1;113(9):691-692. doi: 10.1093/qjmed/hcaa002.
2
Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy.桥本甲状腺炎:流行病学、发病机制、临床与治疗。
Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101367. doi: 10.1016/j.beem.2019.101367. Epub 2019 Nov 26.
3
Fine-needle aspiration to diagnose primary thyroid lymphomas: a systematic review and meta-analysis.细针穿刺诊断原发性甲状腺淋巴瘤:一项系统评价和荟萃分析。
超声在预测原发性甲状腺淋巴瘤患者局部难治/复发事件中的潜在价值。
Cancer Imaging. 2024 Mar 20;24(1):39. doi: 10.1186/s40644-024-00681-z.
4
Surgery is a Viable Treatment Option for Stage IE Primary Thyroid Lymphoma.手术是 IE 期原发性甲状腺淋巴瘤的可行治疗选择。
Ann Surg Oncol. 2024 Feb;31(2):1108-1115. doi: 10.1245/s10434-023-14535-8. Epub 2023 Nov 5.
5
Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis.基于人群分析建立并验证预测 B 细胞原发性甲状腺恶性淋巴瘤特异性生存的列线图
Front Endocrinol (Lausanne). 2022 Oct 11;13:965448. doi: 10.3389/fendo.2022.965448. eCollection 2022.
Eur J Endocrinol. 2019 Mar;180(3):177-187. doi: 10.1530/EJE-18-0672.
4
[Clinicopathological features and treatment outcome of 37 cases of primary thyroid lymphoma].37例原发性甲状腺淋巴瘤的临床病理特征及治疗结果
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Oct;32(20):1551-1556. doi: 10.13201/j.issn.1001-1781.2018.20.005.
5
Benefits of marriage on relative and conditional relative cancer survival differ between males and females in the USA.在美国,婚姻对男性和女性的亲属及条件性亲属癌症生存率的益处有所不同。
J Cancer Surviv. 2017 Oct;11(5):578-589. doi: 10.1007/s11764-017-0627-y. Epub 2017 Aug 2.
6
Diagnosis and Clinical Analysis of Primary Thyroid Lymphoma.原发性甲状腺淋巴瘤的诊断与临床分析
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Jun 20;39(3):377-382. doi: 10.3881/j.issn.1000-503X.2017.03.013.
7
Primary thyroid lymphoma.原发性甲状腺淋巴瘤
Ulus Cerrahi Derg. 2015 Jul 10;32(1):75-7. doi: 10.5152/UCD.2015.2935. eCollection 2016.
8
Rituximab-including combined modality treatment for primary thyroid lymphoma: an effective regimen for elderly patients.含利妥昔单抗的综合治疗方案用于原发性甲状腺淋巴瘤:一种针对老年患者的有效治疗方案
Thyroid. 2014 Jun;24(6):994-9. doi: 10.1089/thy.2013.0523. Epub 2014 May 15.
9
Thyroid lymphoma: recent advances in diagnosis and optimal management strategies.甲状腺淋巴瘤:诊断及最佳管理策略的最新进展
Oncologist. 2013;18(9):994-1003. doi: 10.1634/theoncologist.2013-0036. Epub 2013 Jul 23.
10
Primary thyroid lymphoma: a clinical review.原发性甲状腺淋巴瘤:临床综述。
J Clin Endocrinol Metab. 2013 Aug;98(8):3131-8. doi: 10.1210/jc.2013-1428. Epub 2013 May 28.